Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
ETFs
Etats-Unis
NASDAQ
First Trust Nasdaq ABA Community Bank Index Fund (QABA)
First Trust Nasdaq ABA Community Bank Index Fund (QABA) Options

First Trust Nasdaq ABA Community Bank Index Fund (QABA)

63,0518

0,333

(0,53%)

Fermé 06 Juin 10:00PM

62,87

-0,1818

(-0,29%)

Après les heures de négociation: 1:59AM

First Trust Nasdaq ABA Community Bank Index Fund ([symbol]) Options

QABA Flux des options

Achats

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
53,00	8,60	11,90	0,00	10,25	0,00	0,00 %	0	0	-
54,00	7,60	10,90	0,00	9,25	0,00	0,00 %	0	0	-
55,00	6,60	9,90	0,00	8,25	0,00	0,00 %	0	0	-
56,00	5,60	8,90	0,00	7,25	0,00	0,00 %	0	0	-
57,00	4,70	8,00	6,80	6,35	0,00	0,00 %	0	10	-
58,00	3,70	7,00	4,60	5,35	0,00	0,00 %	0	2	-
59,00	2,80	6,00	0,00	4,40	0,00	0,00 %	0	0	-
60,00	1,95	5,10	0,00	3,525	0,00	0,00 %	0	0	-
61,00	1,15	4,30	0,00	2,725	0,00	0,00 %	0	0	-
62,00	0,40	3,50	0,00	1,95	0,00	0,00 %	0	0	-
63,00	0,15	2,70	0,00	1,425	0,00	0,00 %	0	0	-
64,00	0,00	2,15	0,00	0,00	0,00	0,00 %	0	0	-
65,00	0,00	1,90	0,00	0,00	0,00	0,00 %	0	0	-
66,00	0,00	1,65	0,00	0,00	0,00	0,00 %	0	0	-
67,00	0,00	1,50	0,00	0,00	0,00	0,00 %	0	0	-
68,00	0,00	1,45	0,00	0,00	0,00	0,00 %	0	0	-
69,00	0,00	1,40	0,00	0,00	0,00	0,00 %	0	0	-
70,00	0,00	1,35	0,00	0,00	0,00	0,00 %	0	0	-
71,00	0,00	1,35	0,00	0,00	0,00	0,00 %	0	0	-

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Ventes

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
53,00	0,00	1,35	0,00	0,00	0,00	0,00 %	0	0	-
54,00	0,00	1,35	0,00	0,00	0,00	0,00 %	0	0	-
55,00	0,00	1,35	0,00	0,00	0,00	0,00 %	0	0	-
56,00	0,00	1,40	0,00	0,00	0,00	0,00 %	0	0	-
57,00	0,00	1,40	0,00	0,00	0,00	0,00 %	0	0	-
58,00	0,00	1,45	0,00	0,00	0,00	0,00 %	0	0	-
59,00	0,00	1,50	0,00	0,00	0,00	0,00 %	0	0	-
60,00	0,00	1,60	0,00	0,00	0,00	0,00 %	0	0	-
61,00	0,00	1,80	0,00	0,00	0,00	0,00 %	0	0	-
62,00	0,00	2,05	0,00	0,00	0,00	0,00 %	0	0	-
63,00	0,00	2,45	0,00	0,00	0,00	0,00 %	0	0	-
64,00	0,25	2,95	0,00	1,60	0,00	0,00 %	0	0	-
65,00	0,70	3,80	0,00	2,25	0,00	0,00 %	0	0	-
66,00	1,45	4,60	0,00	3,025	0,00	0,00 %	0	0	-
67,00	2,30	5,50	0,00	3,90	0,00	0,00 %	0	0	-
68,00	3,20	6,50	0,00	4,85	0,00	0,00 %	0	0	-
69,00	4,20	7,50	0,00	5,85	0,00	0,00 %	0	0	-
70,00	5,20	8,50	0,00	6,85	0,00	0,00 %	0	0	-
71,00	6,20	9,50	0,00	7,85	0,00	0,00 %	0	0	-

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SCAGScage Future	US$ 0,8489 (196,61%)	92,75M
SPHLSpringview Holdings Ltd	US$ 5,38 (125,20%)	40,61M
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M
STISolidion Technology Inc	US$ 35,50 (56,32%)	38,55M
NUWENewellis Inc	US$ 0,1625 (-62,30%)	50M
NYXHNyxoah SA	US$ 1,41 (-51,04%)	2,47M
CYPHCypherpunk Technologies Inc	US$ 0,5176 (-47,26%)	30,53M
TDICDreamland Ltd	US$ 0,2277 (-37,68%)	12,09M
FOFOHang Feng Technology Innovation Co Ltd	US$ 3,91 (-36,73%)	381,9k
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
SNBRSleep Number Corporation	US$ 0,477 (36,25%)	305,13M
SMTKSmartKem Inc	US$ 0,419101 (30,97%)	232,19M
NVDANVIDIA Corporation	US$ 205,10 (-6,20%)	220,65M
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M

US Market News

US Market News il y a 3 minutes

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA BerobenatideJune 6, 2026 9:00 AM
Business Wire Results from multiple Phase 2b dose finding studies for berobenatide (PF’3944) highlight a potential first-in

Investor082

Investor082 il y a 4 minutes

They are all a bunch of BS artists! They have trapped many naive retail families over the years by providing false hope and expectations.

Investor082

Investor082 il y a 5 minutes

See you in 2028 then! LP is likely to abandon Eden before that at some point than secure a commercial certification in 2028.

Keep a ton of dry powder. Looking forward to you bragging about averaging down in the coming weeks and months, LOL! ;)

Investor082

Investor082 il y a 8 minutes

In that case, forget about 2026 and 2027. Likely 2028 as well. C lab and Eden won’t certified for commercial production until 2028 at the earliest. Its more likely they will abandon Eden than secure commercial certification even in 2028. Have fun with the endless dilution in pennies! ;)

WhiteOwl

WhiteOwl il y a 10 minutes

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

hardlesson

hardlesson il y a 12 minutes

You're one of the hardest working guys on ihub. Banging out the charts on a Saturday morning. Thanks always, and have a good weekend. :)

Investor082

Investor082 il y a 13 minutes

LP will be back there again in a couple years still pleading for a change (pathway act) so she can submit regulatory application to FDA in 2030, LOL!

Meanwhile outstanding shares ballooned to 5B+, LOL! ;)

WhiteOwl

WhiteOwl il y a 13 minutes

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

glenn1919

glenn1919 il y a 16 minutes

BCDA......BMGL.......BGMS......ACCL......CMND.........CGTL...........https://stockcharts.com/sc3/ui/?s=CMND&p=w&yr=1&mn=3&dy=0&id=p96837884856

Investor082

Investor082 il y a 17 minutes

No excuses when LP disappoints on this, OK?

I will check in on this message whenever there is a decision, LOL! ;)

WhenLambo

WhenLambo il y a 17 minutes

FIFA is already on public record marketing them, what could be bigger than that? They’ll continue to put VuMe out there next week

train21

train21 il y a 19 minutes

DRIVEN IS BACK
so I guess we going to see 5 cents again ? well are we ?

Investor082

Investor082 il y a 20 minutes

Don't let LP and her toxic financiers screw you year after year, LOL! ;)

Instead invest in well known AI and tech stocks run by solid management crew.

glenn1919

glenn1919 il y a 21 minutes

STAK......SPHL.....SMTK......SAOR.....SNBR.......SCAG.....SPPL..................................https://stockcharts.com/sc3/ui/?s=SCAG&p=w&yr=1&mn=3&dy=0&id=p96837884856

jackinthegreen

jackinthegreen il y a 21 minutes

Exactly - another round of press and hype can drive the price up a bit, but without substantial new contracts and revenue outside the consumer electronics space, it will only be a temporary bump. We’ve been here before - buying on the rumor is great, but what we need is actual profitability.

train21

train21 il y a 22 minutes

BOTH CEOs BLOCKED ME ON X
I MUST HAVE HIT THE NAIL ON THE HEAD
ANY CEO THAT BLOCKS QUESTIONS OF THEIR DECISIONS IS HIDING SOMETHING BIG AND BAD ???

rodman

rodman il y a 22 minutes

There appears to be some life left in UEEC based upon the buying and pps increase this week.

cottonmather

cottonmather il y a 23 minutes

Drey Dossier. The WH Ballroom ain't what it used to be. 17 minutes https://youtu.be/VbJ4ilDvGyc?si=DispyZYqLVQNJyms

USAFpatriot

USAFpatriot il y a 23 minutes

Annual meeting 8k.

https://investorshub.advfn.com/stock-market/NASDAQ/novocure-NVCR/stock-news/98686681/form-8-k-current-report

train21

train21 il y a 24 minutes

$GTVH YOU ALL NEED TO FILE COMPLAINTS ON THE $OTC WEB SITE AND THE $FINRA WEB SITE
I CAN NOT JUST BE THE ONLY ONE FILING COMPLAINTS HERE ? SOME OF YOU GUYS LOST THOUSANDS $$$$$
CASEY IS A SHARE SELLING SCAMMMER AND MEDIA POSTING LIAR ......... AND THATS ALL THIS STOCK IS

HGiLS

HGiLS il y a 25 minutes

Absolutely — let’s build the full, structured deep-dive you asked for. Below is everything:

• All Eliquis ANDA filers
• Their litigation outcomes
• Each filer’s non-infringement arguments
• Why none succeeded
• Drugs where generics did win using alternative

peafunke

peafunke il y a 26 minutes

You told ‘who’ so? The fifa concerts are this coming week.

HGiLS

HGiLS il y a 27 minutes

Yes — Eliquis (apixaban) has exactly the kind of ANDA litigation you’re asking about: cases where a generic filer challenged the Orange Book patents and argued non-infringement because their own formulation or manufacturing approach did not fall within the scope of the listed patents.

Teddytropics

Teddytropics il y a 29 minutes

I will leave it up to you to decide..

I ask myself.. why is this guy so obsessed with Jason Black..?

That he wants to 'to tell on Jason Black' to all..

Where Jason Black isn't involved here anymore except for the CNNA OTC page still listing him..

First Trust Nasdaq ABA C...

Manganese X Energy

Great Western Exploration

Frequency Exchange

L&G ETFS All Commodities...

Grana y Montero SAA

Callable Zero Coupon Not...

Volatus Capital

Lyx Scient Beta

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.